help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2002-0150
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
17/3/366    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow NURSA Molecule Pages Link
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sohn, Y.-C.
Right arrow Articles by Lee, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sohn, Y.-C.
Right arrow Articles by Lee, J. W.
Molecular Endocrinology 17 (3): 366-372
Copyright © 2003 by The Endocrine Society

Dynamic Inhibition of Nuclear Receptor Activation by Corepressor Binding

Young-Chang Sohn1, Seung-Whan Kim1, Seunghee Lee1, Young-Yun Kong, Doe Sun Na, Soo-Kyung Lee and Jae Woon Lee

Department of Life Science (Y.-C.S., S.-W.K., S.L., Y.-Y.K., J.W.L.), Pohang University of Science and Technology, Pohang 790-784, Korea; Faculty of Marine Bioscience & Technology (Y.-C.S.), Kangnung National University, Kangnung 210-702, Korea; Department of Biochemistry (D.S.N.), College of Medicine, University of Ulsan, Seoul 138-736, Korea; and Gene Expression Laboratory (S.-K.L.), The Salk Institute for Biological Studies, San Diego, California 92037

Address all correspondence and requests for reprints to: Jae Woon Lee, Ph.D., Department of Life Science, Pohang University of Science and Technology, Pohang 790-784, Korea. E-mail: jaewoon{at}postech.ac.kr; or Young-Chang Sohn, Ph.D., Faculty of Marine Bioscience & Technology, Kangnung National University, Kangnung 210-702, Korea. E-mail: ycsohn{at}kangnung.ac.kr.

Nuclear receptors adopt dramatically different conformations in the presence or absence of ligand, and such liganded (holo) and unliganded (apo) receptors are specifically recognized by transcriptional coactivators and corepressors, respectively. These two states likely exist in dynamic equilibrium, contrary to the conventional model of static off and on conformations. First, corepressor SMRT [for silencing mediator of thyroid hormone receptor (TR) and retinoic acid receptor (RAR)] inhibits the interaction of coactivator steroid receptor coactivator-1 with liganded TR/RAR. Second, SMRT enables receptors to adopt apo-form even in the presence of ligand, as demonstrated with limited proteolyses and decreased binding of radiolabeled retinoid to RAR. Finally, chromatin immunoprecipitation results indicate that SMRT and steroid receptor coactivator-1 dynamically compete for receptor bindings in vivo in the presence of ligand. These results suggest that corepressor binding can drive receptors to adopt the apo-state, even in the presence of ligand, and inhibit activated liganded (holo) nuclear receptors in vivo.

NURSA Molecule Pages Link:

Nuclear Receptors:   TRβ
Coregulators:   SRC-1  |  GRIP1  |  AIB1  |  ASC-2  |  NCOR
Ligands:   9-cis-Retinoic acid  |  Thyroid hormone



This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
K. J. Higgins, S. Liu, M. Abdelrahim, K. Vanderlaag, X. Liu, W. Porter, R. Metz, and S. Safe
Vascular Endothelial Growth Factor Receptor-2 Expression Is Down-Regulated by 17{beta}-Estradiol in MCF-7 Breast Cancer Cells by Estrogen Receptor {alpha}/Sp Proteins
Mol. Endocrinol., February 1, 2008; 22(2): 388 - 402.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
M. Caprio, B. Feve, A. Claes, S. Viengchareun, M. Lombes, and M.-C. Zennaro
Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis
FASEB J, July 1, 2007; 21(9): 2185 - 2194.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
L. Michalik, V. Zoete, G. Krey, A. Grosdidier, L. Gelman, P. Chodanowski, J. N. Feige, B. Desvergne, W. Wahli, and O. Michielin
Combined Simulation and Mutagenesis Analyses Reveal the Involvement of Key Residues for Peroxisome Proliferator-activated Receptor{alpha} Helix 12 Dynamic Behavior
J. Biol. Chem., March 30, 2007; 282(13): 9666 - 9677.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Tudor, J. N. Feige, H. Pingali, V. B. Lohray, W. Wahli, B. Desvergne, Y. Engelborghs, and L. Gelman
Association with Coregulators Is the Major Determinant Governing Peroxisome Proliferator-activated Receptor Mobility in Living Cells
J. Biol. Chem., February 16, 2007; 282(7): 4417 - 4426.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
T. C. Voss, I. A. Demarco, C. F. Booker, and R. N. Day
Functional interactions with Pit-1 reorganize co-repressor complexes in the living cell nucleus
J. Cell Sci., August 1, 2005; 118(15): 3277 - 3288.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. Zechel
Requirement of Retinoic Acid Receptor Isotypes {alpha}, {beta}, and {gamma} during the Initial Steps of Neural Differentiation of PCC7 Cells
Mol. Endocrinol., June 1, 2005; 19(6): 1629 - 1645.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Bour, J.-L. Plassat, A. Bauer, S. Lalevee, and C. Rochette-Egly
Vinexin {beta} Interacts with the Non-phosphorylated AF-1 Domain of Retinoid Receptor {gamma} (RAR{gamma}) and Represses RAR{gamma}-mediated Transcription
J. Biol. Chem., April 29, 2005; 280(17): 17027 - 17037.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. Yu, K. Markan, K. A. Temple, D. Deplewski, M. J. Brady, and R. N. Cohen
The Nuclear Receptor Corepressors NCoR and SMRT Decrease Peroxisome Proliferator-activated Receptor {gamma} Transcriptional Activity and Repress 3T3-L1 Adipogenesis
J. Biol. Chem., April 8, 2005; 280(14): 13600 - 13605.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S.-E. Park, J. Xu, A. Frolova, L. Liao, B. W. O'Malley, and B. S. Katzenellenbogen
Genetic Deletion of the Repressor of Estrogen Receptor Activity (REA) Enhances the Response to Estrogen in Target Tissues In Vivo
Mol. Cell. Biol., March 1, 2005; 25(5): 1989 - 1999.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
D. Kamashev, D. Vitoux, and H. de The
PML-RARA-RXR Oligomers Mediate Retinoid and Rexinoid/cAMP Cross-Talk in Acute Promyelocytic Leukemia Cell Differentiation
J. Exp. Med., April 19, 2004; 199(8): 1163 - 1174.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. L. Abrams, J. Xu, C. Nativelle-Serpentini, S. Dabirshahsahebi, and M. B. Rogers
An Evolutionary and Molecular Analysis of Bmp2 Expression
J. Biol. Chem., April 16, 2004; 279(16): 15916 - 15928.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
C. L. Smith and B. W. O'Malley
Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators
Endocr. Rev., February 1, 2004; 25(1): 45 - 71.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
F. J. Fleming, A. D. K. Hill, E. W. McDermott, N. J. O'Higgins, and L. S. Young
Differential Recruitment of Coregulator Proteins Steroid Receptor Coactivator-1 and Silencing Mediator for Retinoid and Thyroid Receptors to the Estrogen Receptor-Estrogen Response Element by {beta}-Estradiol and 4-Hydroxytamoxifen in Human Breast Cancer
J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 375 - 383.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2003 by The Endocrine Society